Diseases [C] » Musculoskeletal Diseases [C05] » Bone Diseases » Bone Diseases, Developmental » Dwarfism
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Dwarfism
Diseases [C] » Endocrine System Diseases [C19] » Dwarfism
Description
A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height. MeSH
Hierarchy View
Subtype Terms (8)
Achondroplasia
8 drugs (4 approved, 4 experimental)
Cockayne Syndrome
1 approved drug
Congenital Hypothyroidism
2 drugs (1 approved, 1 experimental)
Dwarfism, Pituitary
10 drugs (9 approved, 1 experimental)
Laron Syndrome
1 approved drug
Silver-Russell Syndrome
1 approved drug
Approved Indicated Drugs (3)
Phase 2 Indicated Drugs (2)
Organization Involved with Phase 4 Indications (13)
Organization Involved with Phase 3 Indications (33)
Organization Involved with Phase 2 Indications (7)
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
